Natarajan Sethuraman, Chief Scientific Officer: Entrada Therapeutics TRDA Sell · Filed 23/07/12

Trade details

Type: Insider sale
Amount: $267,930.08
Shares · price: 14,852 sh · $18.04 a share
Held after: 153,447 sh
Stock: Entrada Therapeutics TRDA
Person: Natarajan SethuramanChief Scientific Officer
Trade date: 23/07/11
Filed: 23/07/12
Days to filing: 1 days

Sold 8.8% of holdings

Share of holding sold: 8.8%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/11~23/08/10

Natarajan Sethuraman's recent trades

Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$398.7K
25,907 sh
$398.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$375.7K
25,907 sh
$375.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$235.8K
11,703 sh
$235.8K
Filed 24/12/03
Traded 24/12/03
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$82.8K
4,088 sh
$82.8K
Filed 24/12/03
Traded 24/12/02
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$2,000
100 sh
$2,000
Filed 24/12/03
Traded 24/11/29